Free Design Audit Available - Click Here for Details

MedTech News

Cardio Flow Announces Completion of First Commercial Cases of Innovative FreedomFlow Orbital Atherectomy Platform

ST. PAUL, Minn.–(BUSINESS WIRE)– Cardio Flow, Inc., a privately held commercial-stage medical device company and developer of minimally invasive devices to treat peripheral artery disease (PAD), is pleased to announce the successful completion of its first commercial cases for its FreedomFlow® Orbital Atherectomy Platform following FDA clearance in late September.

Read More »

Sign up for Blog Updates